#KyvernaTherapeutics has reported new data with its #celltherapy for the rare #autoimmunedisease #stiffpersonsyndrome (SPS), miv-cel, that reinforces its safety as it prepares to complete a rolling FDA filing before the end of this year.
@pharmaphorum.bsky.social